Frisco, Texas (PRWEB) December 20, 2011
SomnoMed, Inc., manufacturer of the world's leading oral appliance, SomnoDent for the treatment of Obstructive Sleep Apnea announces that the Armed Services Association (ASA) has confirmed the company’s SomnoDent registration to provide United States Military personnel OSA Treatment.
This registration confirmation coincides with a recent announcement from the US Army Medical Department stating custom made oral “devices that fit within the mouth to prevent upper airway collapse, as an effective first-line treatment, according to two studies conducted by sleep medicine specialists from Walter Reed National Military Medical Center (WRNMMC) in Bethesda, Md.”
"Historically, CPAP has been the primary treatment for OSA, but only half of patients tolerate this therapy, which requires wearing a face mask hooked to a machine each night," said Lt. Col. Christopher Lettieri, M.D., one of the studies' authors, an Army medical director and the chief of sleep medicine in the pulmonary, critical care and sleep medicine department at WRNMMC. "This new data offers a fresh look at adjustable oral appliances as an initial treatment for OSA in both the military and civilian sectors."
The military is interested in the SomnoDent, as alternatives to CPAP systems since some active duty service members deploy to environments where electricity needed to run CPAP machines is not always available. In these cases, reliance on CPAP may result in duty restrictions or separation from service. "Adjustable OAs would eliminate duty assignment limitations associated with CPAP, allowing Soldiers to travel to remote areas as needed," said Lettieri.
SomnoMed’s Key Accounts Manager for United States Military personnel is Alton R. Cheek, who has been actively involved in the sleep therapy and sleep diagnostics business for more than twelve years. Alton may be reached at 214-675-8802 or acheek(at)somnomed(dot)com
SomnoMed is a publically listed dental sleep medicine company (ASX:SOM) providing diagnostic and treatment solutions for Sleep Breathing Disorders such as Obstructive Sleep Apnea. SomnoMed was commercialized on the basis of extensive clinical research. Supporting independent clinical research, continuous innovation and instituting medical manufacturing standards has resulted in SomnoDent becoming the state-of-the-art and clinically proven medical oral appliance therapy for obstructive sleep apnea. SomnoDent is the most comfortable and effective design and treatment solution for over 70,000 patients in 20 countries. For additional information, visit SomnoMed at http://www.somnomed.com.